Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease

Journal of the American Society of Nephrology

Volumn 14, Issue 5, 2003, Pages 1164-1174

  Magistroni, Riccardo ^a,j   He, Ning ^a   Wang, Kairong ^a   Andrew, Robin ^a   Johnson, Ann ^b   Gabow, Patricia ^b   Dicks, Elizabeth ^c   Parfrey, Patrick ^c   Torra, Roser ^d   San Millan, Jose L ^e   Coto, Eliecer ^f   Van Dijk, Marjan ^g   Breuning, Martijn ^h   Peters, Dorien ^h   Bogdanova, Nadja ⁱ   Ligabue, Giulia ^j   Albertazzi, Alberto ^j   Hateboer, Nick ^k   Demetriou, Kyproula ^l   Pierides, Alkis ^l   Deltas, Constantinos ^m   St George Hyslop, Peter ^a   Ravine, David ^k   Pei, York ^a   more..

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF COLORADO   (United States)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^d FUNDACIÓ PUIGVERT   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

^f HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h LEIDEN UNIVERSITY   (Netherlands)

ⁱ UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^j UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^k UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^l NICOSIA GENERAL HOSPITAL   (Cyprus)

^m UNIVERSITY OF CYPRUS   (Cyprus)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GENE; GENE MUTATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PKD1 GENE; PKD2 GENE; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL RATE;

EID: 0037408549     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000061774.90975.25     Document Type: Article

References (49)

1. Gabow PA: Autosomal dominant polycystic kidney disease. N Engl J Med 329: 332-342, 1993
2. Harris PC: Autosomal dominant polycystic kidney disease: Clues to pathogenesis. Hum Molec Genet 8: 1861-1869, 1999
3. Parfrey PS, Bear JC, Morgan J, Cramer BC, McManamon PJ, Gault MH, Churchill DN, Singh M, Hewitt R, Somlo S, Reeders S: The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med. 323: 1085-1090, 1990
4. Ravine D, Walker RG, Gibson RN, Forrest SM, Richards RI, Friend K, Sheffield LJ, Kincaid-Smith P, Danks DM: Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease. Lancet 340: 1330-1333, 1992
5. Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC: The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10: 151-160, 1995
6. International Polycystic Kidney Disease Consortium: Polycystic kidney disease: The complete structure of the PKD1 gene and its protein. Cell 81: 289-298, 1995
7. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S: PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272: 1339-1342, 1996
8. Daoust MC, Reynolds DM, Bichet DG, Somlo S: Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics 25: 733-736, 1995
9. Paterson A, Pei Y: A third gene for autosomal dominant polycystic kidney disease? Kidney Int 54: 1759-1761, 1998
10. Peters DJ, Sandkuijl LA: Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol 97: 128-139, 1992
11. Somlo S, Ehrlich B: Human disease: Calcium signaling in polycystic kidney disease. Curr Biol 11: R356-R360, 2001
12. Hanaoka K, Qian F, Boletta A, Bhunia AK, Piontek K, Tsiokas L, Sukhatme VP, Guggino WB, Germino GG: Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 408: 990-994, 2000
13. Igarashi P, Somlo S: Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol 13: 2384-2398, 2002
14. Koulen P, Cai Y, Geng L, Maeda Y, Nishimura S, Witzgall R, Ehrlich BE, Somlo S: Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol 4, 191-197, 2002
15. Hateboer N, v Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M, Ravine D: Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD 1:PKD 2 Study Group. Lancet 353: 103-107, 1999
16. Rossetti S, Burton S, Strmecki L, Pond G, San Millan J, Zerres K, Barratt TM, Ozen S, Torres V, Bergstralh EJ, Winearls C, Harris PC: The position of the polycystic kidney disease 1 gene mutation correlates with the severity of renal disease. J Am Soc Nephrol 13: 1230-7, 2002
17. Hateboer N, Veldhuisen B, Peters D, Breuning MH, San-Millan JL, Bogdanova N, Coto E, van Dijk MA, Afzal AR, Jeffery S, Saggar-Malik AK, Torra R, Dimitrakov D, Martinez I, de Castro SS, Krawczak M, Ravine D: Location of mutations within the PKD2 gene influences clinical outcome. Kidney Int 57: 1444-1451, 2000
18. Veldhuisen B, Saris JJ, de Haij S, Hayashi T, Reynolds DM, Mochizuki T, Elles R, Fossdal R, Bogdanova N, van Dijk MA, Coto E, Ravine D, Norby S, Verellen-Dumoulin C, Breuning MH, Somlo S, Peters DJ: A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease. Am J Hum Genet 61: 547-555, 1997
19. Viribay M, Hayashi T, Tellefia D, Mochizuki T, Reynolds DM, Alonso R, Lens XM, Moreno F, Harris PC, Somlo S, San Millan JL: Novel stop and frameshifting mutations in the autosomal dominant polycystic kidney disease 2 gene. Hum Genet 101: 229-234, 1997
20. Pei Y, He N, Wang K, Kasenda M, Paterson AD, Chan G, Liang Y, Roscoe J, Brissenden J, Hefferton D, Parfrey P, Somlo S, St George-Hyslop P: A spectrum of mutations in the polycystic kidney disease-2 gene from eight Canadian kindreds. J Am Soc Nephrol 9: 1853-1860, 1998
21. Aguiari G, Manzati E, Penolazzi L, Micheletti F, Augello G, Vitali ED, Cappelli G, Cai Y, Reynolds D, Somlo S, Piva R, del Senno L: Mutations in autosomal dominant polycystic kidney disease 2 gene: Reduced expression of PKD2 protein in lymphoblastoid cells. Am J Kidney Dis 33: 880-885, 1999
22. Demetriou K, Tziakouri C, Anninou K, Elefthefiou A, Koptides M, Nicolaou A, Deltas C, Pierides A: Autosomal dominant polycystic kidney disease-type 2. Ultrasound, genetic and clinical correlations. Nephrol Dial Transplant 15: 205-211, 2000
23. Iglesias DM, Telleria D, Viribay M, Herrera M, Bemath VA, Komblihtt AR, Martin RS, Millan JL: A novel frameshift mutation (2436insT) produces an immediate stop codon in the autosomal dominant polycystic kidney disease 2 gene. Nephrol Dial Transplant 15: 477-480, 2000
24. Torra R, Badenas C, Perez-Oller L, Luis J, Millan S, Nicolau C, Oppenheimer F, Mila M, Darnell A: Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients. Am J Kidney Dis 36: 728-734, 2000
25. Deltas CC: Mutations of the human polycystic kidney disease 2 (PKD2) gene. Hum Mutat 18: 13-24, 2001
26. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343: 824-827, 1994
27. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976
28. Hayashi T, Mochizuki T, Reynolds D, Wu Y, Cai Y, Somlo S: Characterization of the exon structure of the Polycystic Kidney Disease2 gene. Genomics 44: 131-136, 1997
29. Cox DR: Regression models and life-tables. J Royal Statist Soc 34: 187-220, 1972
30. Reynolds D, Hayashi T, Cai YQ, Veldhuisen B, Watnick T, Lens X, Mochizuki T, Qian F, Maeda Y, Li L, Fossdal R, Coto E, Wu GQ, Breuning M, Germino G, Peters D, Somlo S: Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease. J Am Soc Nephrol 10: 2342-2351, 1999
31. Watnick T, He N, Wang KW, Liang Y, Parfrey P, Hefferton D, St. George-Hyslop P, Germino G, Pei Y: Somatic mutations in PKD1 in ADPKD2 tissue suggest a possible pathogenic role of trans-heterozygous mutations. Nature Genet 25: 143-144, 2000
32. Qian F, Watnick TJ, Onuchic LF, Germino GG: The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type 1. Cell 87: 979-987, 1996
33. Koptides M, Hadjimichael C, Koupepidou P, Pierides A, Constantinou Deltas C: Germinal and somatic mutations in the PKD2 gene of renal cysts in autosomal dominant polycystic kidney disease. Hum Mol Genet 8: 509-513, 1999
34. Lu W, Shen X, Pavlova A, Lakkis M, Ward CJ, Pritchard L, Harris PC, Genest DR, Perez-Atayde AR, Zhou J: Comparison of PkdI-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum Mol Genet 10: 2385-2389, 2001
35. Wu GQ, D'Agati V, Cai Y, Markowitz G, Park JH, Reynolds D, Maeda Y, Le TC, Hou H, Kucherlapati R, Edelmann W, Somlo S: Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 93: 177-188, 1998
36. Wilkie A: The molecular basis of genetic dominance. J Med Genet 31: 89-98, 1994
37. Pei Y, Paterson AD, Wang KR, He N, Hefferton D, Watnick T, Germino GG, Parfrey P, Somlo S, St. George-Hyslop P: Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease. Am J Hum Genet 68: 355-363, 2001
38. Hateboer N, Lazarou LP, Williams AJ, Holmans P, Ravine D: Familial phenotype differences in PKD1. Kidney Int 56: 34-40, 1999
39. Pei Y: A "two-hit" model of cystogenesis in autosomal dominant polycystic kidney disease? Trends Mol Med 7: 151-156, 2001
40. Dipple KM, McCabe ER: Modifier genes convert "simple" Mendelian disorders to complex traits. Mol Genet Metab 71: 43-50, 2000
41. Zielenski J, Corey M, Rozmahel R, Markiewicz D, Aznarez I, Casals T, Larriba S, Mercier B, Cutting GR, Krebsova A, Macek M Jr, Langfelder-Schwind E, Marshall BC, DeCelie-Germana J, Claustres M, Palacio A, Bal J, Nowakowska A, Ferec C, Estivill X, Durie P, Tsui LC: Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet 22: 128-129, 1999
42. Carrasquillo MM, McCallion AS, Puffenberger EG, Kashuk CS, Nouri N, Chakravarti A: Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat Genet 32: 237-244, 2002
43. Baboolal K, Ravine D, Daniels J, Williams N, Holmans P, Coles GA, Williams JD: Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Kidney Int 52: 607-613, 1997
44. Perez-Oller L, Torra R, Bandenas C, Mila M, Darnell A: Influence of the angiotensin converting enzyme polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease. Am J Kidney Dis 34: 273-278, 1999
45. van Dijk MA, Breuning MH, Peters DJ, Chang PC: The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 15: 836-839, 2000
46. Schiavello T, Burke V, Bogdanova N, Jasik P, Melsom S, Boudville N, Robertson K, Angelicheva D, Dworniczak B, Lemmens M, Horst J, Todorov V, Dimitrakov D, Sulowicz W, Krasniak A, Stompor T, Beilin L, Hallmayer J, Kalaydjieva L, Thomas M: Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 16: 2323-2327, 2001
47. Persu A, Stoenoiu MS, Messiaen T, Davila S, Robino C, El-Khattabi O, Mourad M, Horie S, Feron O, Balligand JL, Wattiez R, Pirson Y, Chauveau D, Lens XM, Devuyst O: Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 11: 229-241, 2002
48. Walker D, Consugar M, Slezak J, Rossetti S, Torres VE, Winearls CG, Harris PC: The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1. Am J Kidney Dis 41: 90-94, 2003
49. Martin ER, Monks SA, Warren LL, Kaplan NL: A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 67: 146-154, 2000